Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Specialty	445.75M	390.46M	374.12M	378.32M	355.57M
Specialty Growth	14.16%	4.37%	-1.11%	6.40%	11.98%
Avkare	662.95M	531.75M	406.11M	349.01M	293.75M
Avkare Growth	24.67%	30.94%	16.36%	18.81%	-
Affordable Medicines	1.69B	1.47B	1.43B	1.37B	1.34B
Affordable Medicines Growth	14.53%	2.75%	4.81%	1.72%	2.63%
Total	2.79B	2.39B	2.21B	2.09B	1.99B
Total Growth	16.73%	8.20%	5.67%	5.08%	22.51%

Source: S&P Global Market Intelligence.